Literature DB >> 24267407

Cognitive functioning associated with stimulant use in patients with non-affective psychosis, their unaffected siblings and healthy controls.

F J van der Meer1, J H Meijer1, C J Meijer1, W van den Brink1, E Velthorst1.   

Abstract

BACKGROUND: Little is known about the effect of stimulant use (amphetamines, cocaine, ecstasy) on cognitive functioning in schizophrenia patients. The current study examined (1) whether recency and frequency of stimulant use is associated with cognitive functioning and (2) whether these associations differ between psychotic patients, their unaffected siblings and controls.
METHOD: Participants completed a comprehensive cognitive test battery. Stimulant use was assessed by urinalysis and by the Composite International Diagnostic Interview (CIDI). Using random effects regression models, the main effects of Stimulant Use and the interaction with Diagnostic Status on cognitive functioning were assessed.
RESULTS: The interaction term between Stimulant Use and Diagnostic Status was not significant for any of the cognitive outcome variables, indicating similar effects of stimulant use in all three groups. Recent stimulant users showed more errors deficit in verbal learning in comparison to never users (Cohen's d = -0.60, p < 0.005). Lifetime frequent stimulant use was significantly associated with worse immediate and delayed verbal recall, working memory and acquired knowledge (Cohen's d = -0.22 to -0.29, p < 0.005). Lifetime infrequent stimulant use was not associated with significant cognitive alterations in comparison to never use.
CONCLUSIONS: The presence of cognitive deficits associated with lifetime stimulant use is dependent on the frequency of use, with no observed deficits in infrequent users and modest negative effects in frequent users.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24267407     DOI: 10.1017/S0033291713002626

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  3 in total

1.  Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis.

Authors:  Lisa Buchy; Larry J Seidman; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; William Stone; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel H Mathalon; Jean Addington
Journal:  Psychiatry Res       Date:  2015-11-25       Impact factor: 3.222

2.  Sources of nonmedically used prescription stimulants: differences in onset, recency and severity of misuse in a population-based study.

Authors:  Lian-Yu Chen; Eric C Strain; Rosa M Crum; Carla L Storr; Ramin Mojtabai
Journal:  Drug Alcohol Depend       Date:  2014-10-12       Impact factor: 4.492

Review 3.  Therapeutic potential of medicinal marijuana: an educational primer for health care professionals.

Authors:  Yara Mouhamed; Andrey Vishnyakov; Bessi Qorri; Manpreet Sambi; Sm Signy Frank; Catherine Nowierski; Anmol Lamba; Umrao Bhatti; Myron R Szewczuk
Journal:  Drug Healthc Patient Saf       Date:  2018-06-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.